2023 Was a tough calendar year with the biopharma marketplace, with many businesses downsizing and restructuring their workforces to stay afloat. You'll find indications of Restoration, as mergers and acquisitions picked up through the pharmaceutical and lifestyle sciences sector during the latter A part of 2023 and also have continued https://sites.google.com/view/bio-sites/blog